Clinical trial

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

NCT00397358 · Vantive Health LLC, Industry · Withdrawn

Key facts

NCT number NCT00397358
Title Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
Official title Open-label Study to Evaluate the Effects of Once Daily Extraneal (7.5% Icodextrin) Peritoneal Dialysis Solution on Triglyceride Levels in Peritoneal Dialysis Patients
Lead sponsor Vantive Health LLC, Industry
Collaborators Baxter Healthcare Corporation Industry
Status Withdrawn
Phase Phase 4
Study type Interventional
Conditions Peritoneal Dialysis, Hypertriglyceridemia
Intervention type Drug
Interventions Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution
Enrollment 0
Start date Nov 1, 2006
Primary completion Jun 1, 2007
Completion Jun 1, 2007
First posted Nov 9, 2006
Last update posted Mar 3, 2025
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies